NEW YORK (Reuters Health) – Women with early breast cancer who are poorly represented in clinical trials experience poorer survival
Read moreHome ยป
malignant breas
AI in Mammography: Won’t Be Replacing Humans Just Yet
Artificial intelligence (AI) has “a long way” to go before it’s ready for routine use in breast cancer screening, says
Read moreFDA Approves Neoadjuvant Pembro for Triple-Negative Breast Cancer
The US Food and Drug Administration (FDA) has approved the neoadjuvant use of pembrolizumab (Keytruda) in combination with chemotherapy for
Read moreCentral Obesity, Adiposity Tied to Mortality in Black Breast Cancer Patients
(Reuters Health) – Black breast cancer patients with higher adiposity, particularly based on waist-to-hip ratio, are at increased risk of
Read morehydrocodone expectorant
(Reuters Health) – A survey of women with breast cancer who had recently visited social media channels dedicated to breast
Read more